Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Spengler

Showing results (171-180 of 224) with videos related to

Pageof 23
Sort By:
AIDS (London, England)|August 20, 2014
Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markersDiana J Leeming, Evrim Anadol, Robert Schierwagen, et al.
Gastroenterology|April 19, 2006
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirinThomas Berg, Michael von Wagner, Samer Nasser, et al.
Journal of Hepatology|June 20, 2014
A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver diseaseHans Dieter Nischalke, Philipp Lutz, Benjamin Krämer, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 19, 2009
Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infectionAndreas Mas Marques, Tobias Mueller, Justus Welke, et al.
Plos Pathogens|May 16, 2017
Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapyBenjamin Krämer, Felix Goeser, Philipp Lutz, et al.
Genome Medicine|September 3, 2011
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohortKatherine R Smith, Vijayaprakash Suppiah, Kate O'Connor, et al.
Journal of Virology|September 26, 2008
Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costsShadi Salloum, Cesar Oniangue-Ndza, Christoph Neumann-Haefelin, et al.
Hepatology (Baltimore, Md.)|March 4, 2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III StudyChristophe Hézode, Massimo Colombo, Marc Bourlière, et al.
Journal of Affective Disorders|June 25, 2021
Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depressionSusanne Sarkar, Jonas Kemper, Rahul Sarkar, et al.
Journal of Hepatology|May 21, 2019
The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort studyJohann von Felden, Laurent Alric, Sven Pischke, et al.
Pageof 23

Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
AIDS (London, England)|August 20, 2014
Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markersDiana J Leeming, Evrim Anadol, Robert Schierwagen, et al.
Gastroenterology|April 19, 2006
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirinThomas Berg, Michael von Wagner, Samer Nasser, et al.
Journal of Hepatology|June 20, 2014
A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver diseaseHans Dieter Nischalke, Philipp Lutz, Benjamin Krämer, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 19, 2009
Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infectionAndreas Mas Marques, Tobias Mueller, Justus Welke, et al.
Plos Pathogens|May 16, 2017
Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapyBenjamin Krämer, Felix Goeser, Philipp Lutz, et al.
Genome Medicine|September 3, 2011
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohortKatherine R Smith, Vijayaprakash Suppiah, Kate O'Connor, et al.
Journal of Virology|September 26, 2008
Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costsShadi Salloum, Cesar Oniangue-Ndza, Christoph Neumann-Haefelin, et al.
Hepatology (Baltimore, Md.)|March 4, 2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III StudyChristophe Hézode, Massimo Colombo, Marc Bourlière, et al.
Journal of Affective Disorders|June 25, 2021
Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depressionSusanne Sarkar, Jonas Kemper, Rahul Sarkar, et al.
Journal of Hepatology|May 21, 2019
The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort studyJohann von Felden, Laurent Alric, Sven Pischke, et al.
Pageof 23